ClinicalTrials.govpublic full text
Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection
hepatitis c, chronic, chronic hepatitis c, dna vaccine, electroporation, intramuscular (im) injection, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858332
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.